enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q1 2025
Institutional positions in enGene Therapeutics Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −3 vs. Q4 2024
- Shares held
- 40.9M
- −363.2K (−0.9%) vs. Q4 2024
- Total value
- $183.4M
- −$91.3M (−33.2%) vs. Q4 2024
- New holders
- 2
- 7 more added
- Sold out
- 5
- 8 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 30 | $134 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,200 | $5.38K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,921 | $8.61K | 0.00% | +783+68.8% | Added |
| Royal Bank of Canada | 7,915 | $35.0K | 0.00% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 11,700 | $52.4K | 0.04% | −67,219−85.2% | Reduced |
| Toronto Dominion Bank | 14,537 | $65.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 15,832 | $70.9K | 0.00% | −20,034−55.9% | Reduced |
| Pale Fire Capital SE | 17,254 | $77.3K | 0.01% | +2,544+17.3% | Added |
| ADAR1 Capital Management, LLC | 23,799 | $106.6K | 0.02% | +23,799 | New |
| Geode Capital Management, LLC | 29,018 | $130.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 33,842 | $151.6K | 0.00% | −574−1.7% | Reduced |
| MAI Capital Management | 78,067 | $349.7K | 0.00% | +7,756+11.0% | Added |
| Schonfeld Strategic Advisors LLC | 134,084 | $600.7K | 0.00% | +1,824+1.4% | Added |
| Marshall Wace, LLP | 345,397 | $1.55M | 0.00% | −248,345−41.8% | Reduced |
| Vestal Point Capital, LP | 370,000 | $1.66M | 0.12% | 00.0% | Unchanged |
| Morgan Stanley | 436,564 | $1.96M | 0.00% | −2,208−0.5% | Reduced |
| Omega Fund Management, LLC | 526,357 | $2.36M | 1.39% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 528,365 | $2.37M | 0.58% | −31,635−5.6% | Reduced |
| Sr One Capital Management, LP | 747,750 | $3.35M | 0.86% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 891,616 | $3.99M | 0.10% | −28,723−3.1% | Reduced |
| Goldman Sachs Group Inc | 899,086 | $4.03M | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,174,866 | $5.26M | 0.00% | −15,086−1.3% | Reduced |
| Point72 Asset Management, L.P. | 1,241,188 | $5.56M | 0.02% | +16,391+1.3% | Added |
| Adage Capital Partners GP, L.L.C. | 1,571,642 | $7.04M | 0.01% | +41,874+2.7% | Added |
| Bank of America Corp | 2,005,708 | $8.99M | 0.00% | +2,005,708 | New |
| Cormorant Asset Management, LP | 2,323,595 | $10.4M | 0.79% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 3,279,378 | $14.7M | 4.74% | +119,403+3.8% | Added |
| Deep Track Capital, LP | 4,557,575 | $20.4M | 0.66% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 4,994,090 | $22.4M | 1.91% | 00.0% | Unchanged |
| VR Adviser, LLC | 5,046,414 | $22.6M | 1.92% | 00.0% | Unchanged |
| FCPM III Services B.V. | 9,632,561 | $43.2M | 10.43% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −2,106,037−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −23,601−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,342−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,038−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,417−100.0% | Sold out |